Mr Vladimir Mekler – Chairman of the Board of Directors 

 

Mr Vladimir Mekler became Chairman of the Board of Directors in 2016. Mr Mekler was appointed as Non-Executive Director in February 2015. He is a senior and managing partner of “Mekler&Partners”. Mr Mekler specializes in corporate law, including support and structuring of complex contracts, cross-border contracts among others; systems of corporate governance and legal structuring development and optimization with regards to criminal and antitrust legislation; legal support of mergers and acquisitions; corporate disputes settlement; organization and coordination of legal representation and defence in repeat economic and property crimes. Mr Mekler has been a member of the Moscow City Bar since 1980 and is listed in the Moscow Bar’s Book of Honours. He also acted as Vice-chairman of the Presidium of the Moscow City Bar Association from 2003 to 2010. He graduated from the Lomonosov Moscow State University.

 

 

Dr Mark Kurtser is the founder of MD Medical Group, CEO and Member of the Board of Directors. Dr Kurtser began his career as a graduate assistant to the associate professor at the obstetrics and gynaecology department of the Pirogov Medical University. From 1994 to 2012, was Head of the Centre of Family Planning and Reproduction, Health Department of Moscow, the largest public obstetrics hospital in Moscow. From 2003 to 2013, Dr Kurtser was the Chief Obstetrician and Gynaecologist of the City of Moscow. He holds a degree in medicine from Pirogov Medical University in addition to a postdoctoral degree in medicine. Dr Kurtser remains actively involved in the Group’s healthcare practice and day-to-day operations.

 

Mr Simon Rowlands was appointed as an independent non-executive director in September 2012. His other current appointments include non-executive directorships at Spire Healthcare and Avio. In 2017 Mr Rowland founded a private investment company Africa Platform Capital.

Previously Mr Rowlands was a Founding Partner of European private equity firm Cinven Partners, where he established and led the healthcare team and was involved in a number of transactions including those of General Healthcare Group, Spire Healthcare and Classic Hospitals in the UK, USP in Spain and Générale de Santé in France. In July 2012, Mr Rowlands became Senior Adviser at Cinven. Prior to joining Cinven, Mr Rowlands worked with an international consulting firm on multi-disciplinary engineering projects in the UK and southern Africa. He has an MBA in Business, a BSc in engineering and is a chartered engineer.

 

Mr Kirill Dmitriev was elected to the Board of Directors in October 2012. He is CEO of the Russian Direct Investment Fund, Russia’s sovereign wealth fund with reserved capital of $10 billion under management. Working alongside the world’s foremost investors, RDIF makes direct investments in leading, as well as promising, Russian companies.
Prior to becoming CEO of RDIF in 2011, Mr Dmitriev headed a number of large private equity funds and completed a series of landmark transactions, including the sale of Delta Bank to General Electric, Delta Credit Bank to Société Générale, STS Media to Fidelity Investments, among others. Mr. Dmitriev began his career at Goldman Sachs and McKinsey & Company. He holds a BA in Economics with Honors and Distinction from Stanford University and an MBA with High Distinction (Baker Scholar) from the Harvard Business School.